| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Revenue | $1.13B | -3.1% |
| Cost of Revenue | $354.6M | -2.8% |
| Gross Profit | $774.9M | -3.2% |
| R&D Expense | $66.9M | +5.7% |
| SG&A Expense | $294.8M | +22.7% |
| Operating Income | $309.6M | -37.1% |
| Pre-tax Income | $256.6M | -48.2% |
| Income Tax | $33.0M | -58.8% |
| Net Income | $223.6M |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $330.9M | — |
| Accounts Receivable | $22.2M | -85.3% |
| Inventory | $122.8M | +4.1% |
| Current Assets | $664.7M | +127.8% |
| Total Assets | $1.09B | +37.9% |
| Current Liabilities | $301.0M | +83.5% |
| Long-term Debt | $1.60B | — |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $412.2M | -9.7% |
| Capital Expenditures | $23.6M | -35.9% |
| Investing Cash Flow | -$24.0M | +38.8% |
| Financing Cash Flow | -$48.0M | +88.5% |
| Free Cash Flow | $388.6M | -7.4% |
| -46.1% |
| EPS (Basic) | $3.92 | -46.2% |
| EPS (Diluted) | $3.89 | -46.6% |
| Stockholders' Equity |
| -$891.4M |
| -250.0% |